A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Clinical trial NCT01620528 · COMPLETED
Trial details
- NCT number
- NCT01620528
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-22
- Primary completion
- 2014-11-14
- Enrollment
- 872
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.